284 related articles for article (PubMed ID: 11694102)
1. Aspirin as an adjunct to screening for prevention of sporadic colorectal cancer. A cost-effectiveness analysis.
Ladabaum U; Chopra CL; Huang G; Scheiman JM; Chernew ME; Fendrick AM
Ann Intern Med; 2001 Nov; 135(9):769-81. PubMed ID: 11694102
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of colonoscopy in screening for colorectal cancer.
Sonnenberg A; Delcò F; Inadomi JM
Ann Intern Med; 2000 Oct; 133(8):573-84. PubMed ID: 11033584
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. Is aspirin a cost-effective addition to colorectal cancer screening?
Ann Intern Med; 2001 Nov; 135(9):1. PubMed ID: 11759636
[No Abstract] [Full Text] [Related]
4. Cost-effectiveness of screening for colorectal cancer in the general population.
Frazier AL; Colditz GA; Fuchs CS; Kuntz KM
JAMA; 2000 Oct; 284(15):1954-61. PubMed ID: 11035892
[TBL] [Abstract][Full Text] [Related]
5. Comparative effectiveness and cost-effectiveness of screening colonoscopy vs. sigmoidoscopy and alternative strategies.
Sharaf RN; Ladabaum U
Am J Gastroenterol; 2013 Jan; 108(1):120-32. PubMed ID: 23247579
[TBL] [Abstract][Full Text] [Related]
6. Cost effectiveness and projected national impact of colorectal cancer screening in France.
Hassan C; Benamouzig R; Spada C; Ponchon T; Zullo A; Saurin JC; Costamagna G
Endoscopy; 2011 Sep; 43(9):780-93. PubMed ID: 21623557
[TBL] [Abstract][Full Text] [Related]
7. Chemoprevention of colorectal cancer by aspirin: a cost-effectiveness analysis.
Suleiman S; Rex DK; Sonnenberg A
Gastroenterology; 2002 Jan; 122(1):78-84. PubMed ID: 11781283
[TBL] [Abstract][Full Text] [Related]
8. Primary prevention of colorectal cancer with low-dose aspirin in combination with endoscopy: a cost-effectiveness analysis.
Hassan C; Rex DK; Cooper GS; Zullo A; Launois R; Benamouzig R
Gut; 2012 Aug; 61(8):1172-9. PubMed ID: 21997545
[TBL] [Abstract][Full Text] [Related]
9. Cost-effectiveness analysis on screening for colorectal neoplasm and management of colorectal cancer in Asia.
Tsoi KK; Ng SS; Leung MC; Sung JJ
Aliment Pharmacol Ther; 2008 Aug; 28(3):353-63. PubMed ID: 18638075
[TBL] [Abstract][Full Text] [Related]
10. Cost-effectiveness of colorectal cancer screening: comparison of community-based flexible sigmoidoscopy with fecal occult blood testing and colonoscopy.
O'Leary BA; Olynyk JK; Neville AM; Platell CF
J Gastroenterol Hepatol; 2004 Jan; 19(1):38-47. PubMed ID: 14675241
[TBL] [Abstract][Full Text] [Related]
11. Combination aspirin and/or calcium chemoprevention with colonoscopy in colorectal cancer prevention: cost-effectiveness analyses.
Pence BC; Belasco EJ; Lyford CP
Cancer Epidemiol Biomarkers Prev; 2013 Mar; 22(3):399-405. PubMed ID: 23250933
[TBL] [Abstract][Full Text] [Related]
12. Effect of rising chemotherapy costs on the cost savings of colorectal cancer screening.
Lansdorp-Vogelaar I; van Ballegooijen M; Zauber AG; Habbema JD; Kuipers EJ
J Natl Cancer Inst; 2009 Oct; 101(20):1412-22. PubMed ID: 19779203
[TBL] [Abstract][Full Text] [Related]
13. Fecal DNA testing compared with conventional colorectal cancer screening methods: a decision analysis.
Song K; Fendrick AM; Ladabaum U
Gastroenterology; 2004 May; 126(5):1270-9. PubMed ID: 15131787
[TBL] [Abstract][Full Text] [Related]
14. Which colon cancer screening test? A comparison of costs, effectiveness, and compliance.
Vijan S; Hwang EW; Hofer TP; Hayward RA
Am J Med; 2001 Dec; 111(8):593-601. PubMed ID: 11755501
[TBL] [Abstract][Full Text] [Related]
15. Aspirin chemoprevention in patients with increased risk for colorectal cancer: a cost-effectiveness analysis.
DuPont AW; Arguedas MR; Wilcox CM
Aliment Pharmacol Ther; 2007 Aug; 26(3):431-41. PubMed ID: 17635378
[TBL] [Abstract][Full Text] [Related]
16. Cutting cost and increasing access to colorectal cancer screening: another approach to following the guidelines.
Fisher JA; Fikry C; Troxel AB
Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):108-13. PubMed ID: 16434595
[TBL] [Abstract][Full Text] [Related]
17. Cost-effectiveness analysis of colorectal cancer screening with stool DNA testing in intermediate-incidence countries.
Wu GH; Wang YM; Yen AM; Wong JM; Lai HC; Warwick J; Chen TH
BMC Cancer; 2006 May; 6():136. PubMed ID: 16723013
[TBL] [Abstract][Full Text] [Related]
18. Evaluating test strategies for colorectal cancer screening: a decision analysis for the U.S. Preventive Services Task Force.
Zauber AG; Lansdorp-Vogelaar I; Knudsen AB; Wilschut J; van Ballegooijen M; Kuntz KM
Ann Intern Med; 2008 Nov; 149(9):659-69. PubMed ID: 18838717
[TBL] [Abstract][Full Text] [Related]
19. Cost-effectiveness of computed tomographic colonography screening for colorectal cancer in the medicare population.
Knudsen AB; Lansdorp-Vogelaar I; Rutter CM; Savarino JE; van Ballegooijen M; Kuntz KM; Zauber AG
J Natl Cancer Inst; 2010 Aug; 102(16):1238-52. PubMed ID: 20664028
[TBL] [Abstract][Full Text] [Related]
20. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
